Skip to main content

Advertisement

Table 2 Variations of fever, parasitaemia and haemoglobin over the time in the studies in Boende and Kabal

From: Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies

Characteristics
N
Boende Kabalo
SP
107
AQ
106
AS+SP
91
AS+AQ
90
p SP
60
AS+SP
62
AS+AQ
58
p
Proportion febrile d1 (%) 20/106
(18.7)
9/105
(8.5)
8/91
(8.8)
5/89
(5.6)
0.01 9/59
(15.3)
5/62
(8.1)
5/58
(8.6)
0.37
Proportion febrile d2 (%) 21/103
(20.4)
3/105
(2.8)
3/91
(3.3)
2/87
(2.2)
<0.001 13/58
(22.4)
1/62
(1.6)
1/58
(1.7)
<0.001
Proportion parasitaemic d2(%) 84/103
(81.5)
90/105
(85.7)
60/91
(65.9)
56/87
(64.4)
<0.001 35/58
(60.3)
8/62
(12.9)
9/58
(15.5)
<0.001
Proportion parasitaemic d7(%) 12/97
(11.4)
6/98
(6.1)
25/89
(28.1)
25/85
(29.4)
<0.001 5/51
(9.8)
7/60
(11.7)
1/54
(1.8)
0.12
Hb d0
median [range]
9.7
[6.0–12.7]
9.7
[5.0–11.7]
9.7
[6.7–12.7]
9.7
[6.7–12.7]
  10.7
[6.7–12.7]
10.7
[6.7–14.0]
10.7
[6.0–14.0]
 
Anaemia* d0 (%) 100
(93.4)
102
(96.2)
83
(91.2)
83
(92.2)
0.51 31
(51.7)
39
(62.9)
36
(62.1)
0.38
Hb d28
median [range]
10.7
[6.7–12.7]
10.7
[6.7–12.7]
10.7
[7.0–12.7]
10.7
[7.3–12.7]
  11.7
[10.7–12.7]
11.7
[9.7–12.7]
11.7
[9.7–14.0]
 
  1. * Defined by haemoglobin below 11 g/dL